Risk for developing cancer rises substantially as a result of poorly regulated inflammatory responses to pathogenic bacterial infections. Anti-inflammatory CD4 þ regulatory cells (T REG ) function to restore immune homeostasis during chronic inflammatory disorders. It seems logical that T REG cells would function to reduce risk of inflammation-associated cancer in the bowel by down-regulating inflammation. It is widely believed, however, that T REG function in cancer mainly to suppress protective anticancer inflammatory responses. Thus roles for inflammation, T REG cells, and gut bacteria in cancer are paradoxical and are the subject of controversy. Our accumulated data build upon the ''hygiene hypothesis'' model in which gastrointestinal (GI) infections lead to changes in T REG that reduce inflammation-associated diseases. Ability of T REG to inhibit or suppress cancer depends upon gut bacteria and IL-10, which serve to maintain immune balance and a protective anti-inflammatory T REG phenotype. However, under poorly regulated pro-inflammatory conditions, T REG fail to inhibit and may instead contribute to a T helper (Th)-17-driven procarcinogenic process, a cancer state that is reversible by down-regulation of inflammation and interleukin (IL)-6. Consequently, hygienic individuals with a weakened IL-10and T REG -mediated inhibitory loop are highly susceptible to the carcinogenic consequences of elevated inflammation and show more frequent inflammation-associated cancers. Taken together, these data help explain the paradox of inflammation and T REG in cancer and indicate that targeted stimulation of T REG may promote health and significantly reduce risk of cancer.
INTRODUCTION
It has become clear that the risk for developing cancer rises substantially as a result of poorly regulated chronic inflammatory responses. Increasing medical and scientific data point to a balance of pro-and anti-inflammatory immune events within the body that dictate outcomes of human health and disease ). An excellent overview by Powrie and Maloy (2003) published in the journal Science describes cells and factors that modulate immune homeostasis. In this context, anti-inflammatory CD4þCD45RB l CD25þ regulatory T cells (T REG ) offer protection from destructive systemic immune events in both humans and mice. We postulate that risk for colorectal cancer (CRC) is greatest when interrelated activities of T REG cells, intestinal bacteria, and innate immunity are unable to restore and support systemic homeostasis.
A functional link between chronic inflammation and cancer has long been suspected, but the crucial molecular pathways that permit communication between cancer cells and inflammatory cell infiltrates largely remain unknown (Coussens and Werb 2002) . Evidence for key roles of tumor necrosis factor (TNF)-a and interleukin (IL)-6 in carcinogenesis are summarized by Balkwill and Coussens in Nature (2004) . Data from several inflammation-associated cancer models implicate TNF-a, IL-6, and nuclear factor (NF)-kB as central players bridging inflammation and tumorigenesis as presented by Karin in Nature (2006) . Interleukin-6 is also pivotal in carcinogenesis and is associated with gender disparity in cancer (Bromberg and Wang 2009; Naugler et al. 2007 ). In humans, men are up to 70% more likely than women to suffer from colon cancer and dysregulated IL-6 (J. Lin et al. 2007; Burch et al. 1975 ). Interleukin-6 may function through activation of Stat3 phosphorylation in tumor cells, resulting in inhibition of dendritic cell maturation (Berishaj et al. 2007; Menetrier-Caux et al. 1998 ). Interleukin-6 can also have direct effects on tumor cells, leading to increased cell migration (Badache and Hynes 2001) and loss of apoptosis (Badache and Hynes 2001; M. T. Lin et al. 2001 ). An important pathogenic role for IL-6 has also emerged in social stress, bereavement, cachexia, and aging in humans and in animal models (Galtgalvis et al. 2008; Kiecolt-Glaser et al. 2003; Meagher et al. 2007; Pace et al. 2006) . Recent studies by Kuchroo and coworkers (Bettelli et al. 2006; ) involving autoimmunity show that ability of T REG to inhibit or suppress inflammation depends up levels of TNF-a and IL-6. In this paradigm, elevated levels of IL-6 trigger a shift towards T helper-type (Th)-17 host response, rather than an anti-inflammatory T REG phenotype, that further contributes to pathology.
Specific events that trigger carcinogenic inflammatory processes are unknown. In the gastrointestinal tract, bacterial infections are associated with carcinogenic inflammatory host responses in humans (Fox and Wang 2007) and mice . Helicobacter pylori bacteria, for example, is classified as a carcinogen by the World Health Organization (WHO) (Correa 2003; Fox and Wang 2007) and has been convincingly linked with stomach cancer in people (El-Omar and Malfertheiner 2001; Ley and Parsonnet 2000; Parsonnet et al. 1991; Peek and Blaser 2002; Williams and Pounder 1999) . A related organism, Helicobacter hepaticus (Ward et al. 1994; Ward et al. 1996) , induces CRC in mice . Interestingly, extra-intestinal tumors also arise in mammary gland and other tissues after infection with H. hepaticus (Rao, Poutahidis, Ge, Nambiar, Boussahmain et al. 2006 ) and may be explained by an immune imbalance favoring TNF-a-and IL-6-mediated systemic inflammatory events . It would follow logically that measures aimed at decreasing inflammation would be beneficial for cancer. Indeed, systemic nonsteroidal anti-inflammatory drug (NSAID) use has been linked with a significant decrease in both sporadic and familial colon cancers in humans (Labayle et al. 1991; Marnett and DuBois 2002; Waddell et al. 1983 ).
THE HYGIENE HYPOTHESIS MODEL AND INFLAMMATION
Paradoxically, risk of developing inflammation-associated cancer, such as CRC, is increased in societies with rigorous hygiene practices (Fox et al. 2000) , even though individuals have less exposure to bacterial pathogens. Although these improvements in cleanliness have had a dramatic effect on suppressing the incidence of many serious gastrointestinal (GI) infections, with increased hygiene there has also been a concomitant increase in the incidence of several other lifethreatening ailments including allergies, autoimmune diseases, and some types of cancer (Belkaid and Rouse 2005; Fox et al. 2000; Weiss 2002 ). The ''hygiene hypothesis'' suggests possible beneficial effects of infections in prevention of diseases. This hypothesis is supported by observations that early childhood infections are associated with reduced frequency of aberrant immune reactions such as allergies and asthma later in life (Weiss 2002) . The observation that childhood infections suppress diseases associated with inflammation raises the possibility that these same infections may also protect against inflammation-associated cancers.
Prior work in our laboratory Rao, Poutahidis, Ge, Nambiar, Boussahmain et al. 2006; Rao et al. 2007 ) and others (Kullberg et al. 2002; Mazmanian et al. 2008) has provided support for a model in which earlier enteric infections suppress inflammatory bowel disease (IBD) and cancer by modulating T REG responses, consistent with the observations of Belkaid and Rouse (2005) . Specifically, we showed that the beneficial cancer-suppressing effects of microbial infections are dependent on IL-10 (Erdman et al. 2005; Erdman, Rao, et al. 2003; Poutahidis et al. 2007; Rao, Poutahidis, Ge, Nambiar, Boussahmain, et al. 2006 ), a cytokine that also provides suppressive and feedback inhibitory effects on allergy and autoimmune responses (Wills-Karp et al. 2001) . Early life exposures to microbial products impart benefit of protection from allergies and asthma in people. Although the hygiene hypothesis has been considered in depth for etiology of allergy and auto-immune diseases, few studies other than our own Rao, Poutahidis, Ge, Nambiar, Boussahmain et al. 2006; Rao et al. 2007 ) have addressed these concepts as they may relate to inflammation-associated cancers in the colon or in extraintestinal sites.
Our perspective that T REG cells may be beneficial in cancer is soundly reasoned and well supported by research data, but challenges the existing paradigm for T REG cells in cancer.
Taken together, observations in our labs and others link the immune system, GI infections, and seemingly divergent downstream phenotypes: allergies, autoimmune disease, and cancer. Our perspective of a possible beneficial role for antiinflammatory T REG in cancer contrasts with the widely held belief that T REG function mainly to suppress protective anticancer inflammatory responses (Colombo et al. 2007; Curiel 2008; Curiel et al. 2004) . Exploring this concept in which childhood infections protect from inflammatory diseases later in life, we have tested T REG biology in different mouse models to help explain unanswered questions about inflammation and cancer risk.
MOUSE MODELS OF CRC
Colorectal cancer is ranked second among the deadliest cancers in this country (American Cancer Society [ACS] 2004; Crawford 1999) . Murine models mimicking human disease are attractive for cancer research because of their small size and short mammalian lifespan, well-established characterization, and the availability of genetically modified animals (Kobaek-Larsen et al. 2000) . Many studies in mice link chronic bacterial infection with cancer in the lower bowel (Engle et al. 2002; Erdman, Rao, et al. 2003; Kado et al. 2001) . We have developed a novel model of colitisassociated CRC (Erdman et al. 2001; Erdman, Rao, et al. 2003) using 129Sv/Ev mice with targeted disruption of the recombinase-activating gene-2 (Rag2-/-). Rag2-/-mice lack functional lymphocytes (Shinkai et al. 1992) and provide a reproducible model to dissect inflammatory events within innate immunity or to test roles for select subsets of adaptive immune cells (see Table 1 ) Maloy et al. 2003) . Helicobacter hepaticus, a common enteric bacterium of mice (Ward et al. 1994) rapidly triggers IBD and associated CRC in Rag2deficient mice. Matched 129 wild-type (wt) mice, however, do not develop bowel pathology after H. hepaticus infection. This finding indicates that gut bacteria-triggered innate immune inflammatory responses are sufficient for cancer (see Figure 1 ), and that cells of adaptive immunity, when working properly, serve to inhibit cancer development and growth ( Figure 1E ). Lesions in this mouse model resemble CRC in human patients with IBD according to the criteria established by the recent ''Pathology of Mouse Models of Intestinal Cancer: Consensus Report'' (Boivin et al. 2003) .
Host inability to properly regulate inflammation and wound healing leads to cancer. During normal wound healing, CD4þ lymphocytes accelerate innate immune pro-inflammatory responses to eliminate pathogenic organisms, and then afterwards CD4þ T REG downregulate inflammation to minimize tissue destruction.
In most human patients, however, CRC is not directly linked with IBD and is more sporadic in nature. Sporadic CRC arises from intestinal adenomatous polyps that undergo a well-characterized series of genetic mutations (Fearon and Vogelstein 1990) , rather than from IBD-associated premalignant foci (Riddell et al. 1983 ). Inactivation of the Apc tumor suppressor gene is an early event in this gene mutation sequence that leads to adenoma growth and dysplasia (Fearon and Vogelstein 1990; Powell et al. 1992) . These preneoplastic events have been widely studied in mice with a mutated Apc gene (Apc Min/þ or Min) that rapidly develop intestinal polyposis (Moser et al. 1990 ). Bowel pathology associated with the Apc Min/þ model is displayed in Figure 2 . Although many environmental factors such as diet and steroidal hormones clearly contribute to colon cancer (Crawford 1999) , underlying inflammatory factors are also proved to be important in progression of sporadic CRC.
CANCER GROWTH REQUIRES SUSTAINED HOST INFLAMMATORY RESPONSES
Pro-inflammatory cytokines are needed to sustain intestinal adenomatous polyps in the Apc Min/þ mice, even though overt colitis is not a typical feature of polyps in mice or in humans.
Anti-inflammatory NSAID usage has been linked with a significant decrease in both sporadic and familial colon cancers in humans (Labayle et al. 1991; Marnett and DuBois 2002; Waddell et al. 1983 ). Studies using Rag2-deficient mice lacking lymphocytes have determined that cancer arises from intestinal bacteria-triggered innate immune events requiring pro-inflammatory cytokines Poutahidis et al. 2007; Poutahidis, et al. 2009; Rao, Poutahidis, Ge, Nambiar, Boussahmain et al. 2006) . It is now widely recognized that inflammation is required for cancer progression in many tissues such as colon and liver in humans and in mice (Balkwill and Coussens 2004; Balkwill, Charles, and Mantovani 2005; Balkwill and Mantovani 2001) . A requirement for inflammation was explicitly shown by Poutahidis et al. (2007) in K-ras-associated carcinoma in mice ( Figure 3 ) whereby systemic administration of anti-TNF-a antibodies or antiinflammatory IL-10-Ig fusion protein induced complete remission of cancer and abolished peritoneal neoplastic invasion ). Although innate immune inflammatory events are sufficient for cancer in Rag-deficient mice (Erdman, , we have shown that CD4þ cells clearly contribute to cancer in immunologically intact hosts (Table 1 ). In these mouse models, chronic inflammation undermines protective functions of T REG cells ( Figure  4 ). Earlier studies by Faubion et al. (2004) in mice revealed that chronic inflammation arising from the bowel may induce thymic involution and T REG suppression, leading to a downward spiral of destructive inflammatory-mediated events that worsen arthritis and IBD (Faubion et al. 2004; Ehrenstein et al, 2004) . Restoration of homeostasis through suppression of TABLE1.-Mouse models of colorectal cancer (CRC) in humans.
Uncontrolled inflammatory immune events increase the risk of developing cancer. Rag2-deficient mice lack lymphocytes that regulate inflammation (T REG ) and as a result are highly susceptible to bacteria-triggered colitis and cancer. Pro-inflammatory cytokines are needed to sustain colonic carcinoma growth in mice, whether or not overt inflammatory disease is evident in cancer. showed that neutralization of pro-inflammatory cytokine TNF-a is sufficient to induce intestinal tumor remission in Apc Min/þ mice, at least in part by restoring homeostasis among CD4þ lymphocytes . Adoptive transfer of syngeneic IL-10-competent T REG also rapidly restored normal bowel in Apc Min/þ mice; T REG potency to suppress tumors is increased by prior exposures to gut bacteria. These accumulated data point to novel therapeutic approaches for colon cancer in humans.
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ERDMAN AND POUTAHIDIS TOXICOLOGIC PATHOLOGY FIGURE 1.-Inflammation modulates colon cancer progression in mice. Innate immune inflammatory response is sufficient for development of bacteria-triggered CRC in Rag2-deficient mice that entirely lack functional lymphocytes. Intramucosal carcinoma and invasion of isolated glands within the submucosa or muscle layers are readily observed in the colon of Rag2-/-mice two to three months after infection with pathogenic H. hepaticus. Mucinous carcinoma with transmural invasion is a uniform feature after six to eight months postinfection (A) and is the dominant histological type of CRC found in this model. Occasionally, other histological types were encountered, including poorly differentiated intramucosal ''medullary'' adenocarcinoma (B) and signet ring cell adenocarcinoma (C). Adoptive transfer with pro-inflammatory effector T (T EFF ) cells into H. hepaticus-infected mice increased the frequency and diversity of CRC, including adenosquamous carcinoma arising from the anus (D) and extending into the transverse colon. In contrast, anti-inflammatory therapy disrupted the carcinogenic network and even abolished established neoplastic invasion. Normal colon mucosa (E) results after adoptive transfer of anti-inflammatory regulatory T (T REG ) cells. Treatment of mice with anti-TNF-a or supplementation with IL-10-Ig fusion protein had similar therapeutic effects. T REG cells require anti-inflammatory IL-10 to prevent pathology, as T REG cells derived from IL-10-deficient donor mice instead greatly exacerbate frequency and the severity of mucinous CRC lesions (F), and peritoneal invasion was a consistent feature. Features of malignancy and neoplastic invasion were associated with increased local and systemic levels of pro-inflammatory cytokines TNF-a, IL-6, and IL-17. Hematoxylin and eosin. Bars: A, E, and F, 250 mm; B and D, 100 mm; C, 50 mm. Features of malignancy and neoplastic invasion were associated with increased local and systemic levels of pro-inflammatory cytokines TNF-a, IL-6, and IL-17. Multiplicity of polyps and intramucosal neoplasia and early neoplastic invasion were also increased by (D) depletion of CD25þ cells. Rag2-/-Apc Min/þ mice, which completely lack lymphocytes, are at greater risk for malignant transformation of adenomas into invasive mucinous adenocarcinoma (E) . Surprisingly, features of malignancy were increased in these mice, commensurate with increased levels of pro-inflammatory cytokines, even in the absence of overt inflammatory disease. The same anti-inflammatory treatments that rescued Rag2-deficient mice with colitis-associated CRC also lead to regression of adenomas and CRC in Apc Min/þ mice. Morphology of a minute polyp (F) not only is representative of adenoma regression seen in Rag2-deficient Apc Min/þ mice after treatment with regulatory T cells (T REG ), but it also typifies the effect of other anti-inflammatory treatments such as systemic neutralization of TNF-a or supplementation with IL-10-Ig fusion protein. Hematoxylin and eosin. Bars, 250 mm.
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TNF-a and reinforcement of T REG cells were proposed for human patients suffering from IBD and other uncontrolled inflammatory disorders. These data on IBD lend support to the concept that uncontrolled inflammation weakens the T REGmediated inhibitory loop and elevates risk for inflammationassociated carcinogenesis.
In humans, inappropriate inflammatory responses with sustained systemic elevations of pro-inflammatory cytokine TNF-a may lead to many disabling conditions such as arthritis and IBD (Ehrenstein et al. 2004 ). Highly efficacious anti-inflammatory therapeutic interventions using monoclonal antibodies against TNF (infliximab) and TNF-binding fusion proteins (etanercept) are in widespread use in human patients with IBD and arthritis (Ehrenstein et al. 2004; Pereg and Lishner) , albeit with reduced protection from bacterial infections. These antibody treatments demonstrate the requirement for TNFa in inflammatory disorders in patients (Greten et al. 2004; Lewis and Pollard 2006; Pollard 2004) . Humans with elevated TNF-a levels also have poor cancer outcomes (Balkwill et al. 2005; Balkwill and Coussens 2004; Balkwill and Mantovani et al. 2001 ). Likewise, our neutralization studies using anti-TNF-a antibodies in Rag2-/-and in Apc Min/þ mice show that inflammation is absolutely required for maintenance of both IBD-associated and polyp-associated intestinal tumors in mice Gounaris et al. 2007; Poutahidis et al. 2007; Poutahidis et al. 2009; Rao, Poutahidis, Ge, Nambiar, Boussahmain, et al. 2006; . Treatment with anti-TNF-a in mice ablates cancer and normalizes expression of cyclooxygenase (Cox)-2, and downstream oncogenes c-myc ) and K-ras ) that are linked with cancer in humans. Our studies in mouse models of intestinal cancer indicate that anti-inflammatory treatments not only prevent cancer from arising, but also abolish established neoplasms. These results suggest that tumor growth and survival may be more dependent upon inflammatory events and more readily reversible than previously thought. The reliance upon inflammatory cells and factors was demonstrated in mouse models of the typical colitis-associated cancer and in mouse models emulating sporadic colorectal cancer (CRC) in humans, as well. Modified from Poutahidis et al. (2007) . Vol. 38, No. 1, 2010 INFLAMMATION 
ROLES FOR T REG CELLS AND INFLAMMATION IN IBD-ASSOCIATED CRC
Medical and scientific data from humans and mouse models indicate that it is the balance between pro-and antiinflammatory activities within the body that predicts the likelihood of developing diseases . During pathogenic microbial challenges, a robust pro-inflammatory response mediated by CD4þCD45RB hi (T EFF ) cells serves to eliminate pathogenic bacteria. Educated CD4þCD45RB l T REG cells subsequently down-regulate inflammation and offer protection from destructive immune sequelae. showed that IL-10-dependent functions of T REG cells protect from malignancy. Roles for T REG subsets in this process are not completely understood. Interestingly, antigen-specific, IL-10-dependent protection from IBD was enriched for in CD4þCD45RB l CD25-cells (Kullberg et al. 2002) . found that the greatest protection from cancer resided in both CD25þ and CD25-CD4þCD45RB l T REG subsets, with the greatest potency arising from combined effects of CD4þ subsets (Rao, Poutahidis, Ge, Nambiar, Boussahmain, et al. 2006; . Nonetheless, host inability to coordinate IL-10 and T REG to resolve inflammation and restore homeostasis greatly increases the risk for developing cancer.
T REG cells are pivotal in immune homeostasis and overall health due, at least in part, of coordinated activities of cytokines IL-10 and transforming growth factor (TGF)-b . A requirement for IL-10 in immune homeostasis has been amply demonstrated in murine models entirely lacking this cytokine that are highly susceptible to bacteriatriggered IBD (Asseman et al. 1999; Kullberg et al. 2002) . Deficiency in IL-10 increases susceptibility to inflammationassociated mucinous carcinoma, resembling CRC, which carries a poor prognosis in humans (Boivin et al. 2003) . Mice lacking IL-10 are susceptible to IBD-CRC after infection with H. hepaticus; however, their wt counterparts infected with H. hepaticus have only minimal bowel pathology Erdman, Rao, et al. 2003; Poutahidis et al. 2007 ). Poutahidis et al. (2007) proposed this difference is a result of interrelated activities of IL-10, TGFb-1, and IL-6 in disrupted wound healing, an effect that is exacerbated in male mice. As predicted, lack of IL-10 leads to increased susceptibility to chronic inflammation with elevated levels of TNF-a, IL-6, and IL-17 (Kullberg et al. 2006; Poutahidis et al. 2007 ). Proposed interrelated roles for these cells and factors are shown in Figure 4 .
In colitis-associated CRC, overexpression of IL-17 coincided not only with the site of H. hepaticus infection in the lower bowel, but also within lymph nodes throughout the body ( Figure  5A ). This finding supported a simplistic model, whereby CD4þ cells insufficient in IL-10 were preferentially recruited to a Th-17 phenotype when faced with a robust pro-inflammatory challenge Bettelli and Kuchroo 2005; Bettelli et al. 2006; Bettelli, Korn et al. 2007; Bettelli, Oukka et al. 2007; Korn, Reddy et al. 2007; , in this case infection with H. hepaticus. This state was readily reversible using exogenous IL-10 ). Bacteria-triggered inflammation in mice mobilized neutrophils bearing TGF-b1 ( Figure 5C ) and IL-6 ( Figure 5D ), which may serve to inhibit T REG and promote a Th-17 host response. Depletion studies indicate an important role for innate immune cells such as neutrophils and for mast cells in malignancy (Gounaris et al. 2007; Erdman et al. 2009 ). Thus, under conditions of insufficient IL-10, there is poor regulation of inflammation and levels of IL-6, which contribute to cancer growth (Erdman, Rao, et al. 2003; Poutahidis et al. 2007) . Taken together, these data support that individuals with insufficient IL-10 are more susceptible to uncontrollable inflammation and effects of IL-6 and Th-17, and they may show more frequent inflammationassociated cancers in response to pro-inflammatory challenges such as pathogenic enteric bacteria later in life.
GUT BACTERIAL INFECTIONS TRIGGER PROTECTIVE IL-10-DEPENDENT T REG CELLS
To test directly whether infections earlier in life, such as childhood bacterial exposures in humans, may protect from immune-mediated diseases later in life, we have used a T REG cell titration as in Rao, Poutahidis, Ge, Nambiar, Boussahmain (2006) . We found that potency to protect from IBD-associated CRC was increased when T REG cells came from wt donor mice that were previously exposed to H. hepaticus bacteria. Curiously, the lower dosages (1Â10 5 cells) of T REG cells from uninfected donor mice (e.g., ''hygienic'' donors) actually had increased neoplastic epithelial invasion, matching what is observed under conditions of insufficient IL-10 in T REG cells. Taken together, these findings led us to postulate that individuals with insufficiently educated T REG , such as those arising under hygienic conditions, are predisposed to sustained inflammatory responses and subsequently have a lowered threshold for carcinogenesis (Erdman et al. 2005; Erdman, Rao, et al. 2003) . Proposed interrelated roles for bacteria, innate immunity, and T REG in health and under preneoplastic conditions are shown in Figure 6 .
ROLES FOR T REG CELLS AND INFLAMMATION IN SPORADIC OR FAMILIAL CRC
To test whether roles for T REG cells in sporadic or familial CRC also conform to the paradigm of IL-6 and IL-17 as in autoimmunity, we have examined C57BL/6 mice heterozygous for a mutation in the Apc gene (Apc Min/þ ). Apc Min/þ mice are genetically at risk for intestinal polyps and mimic early stages of sporadic CRC in humans (Moser et al. 1990; Powell et al. 1992) . Although polyp-CRC is less clearly associated with overt inflammation than IBD-CRC, Apc Min/þ mice have higher systemic and intestinal levels of cytokines TNF-a, IL-6, and IL-17 than matched wt mice, indicative of subclinical inflammatory disease. Importantly, these data match findings of 82 ERDMAN AND POUTAHIDIS TOXICOLOGIC PATHOLOGY elevated inflammatory cytokine levels in human patients with colon cancer (Bromberg and Wang 2009 ). An important role for pro-inflammatory lymphocytes in cancer was demonstrated by , using adoptive transfer of CD4þCD45RBhi (T EFF ) cells, a cell-transfer paradigm otherwise used in mice to emulate autoimmunity in humans . Cell transfer of T EFF increased tumor FIGURE 5.-Immunohistochemical detection of critical inflammatory cells and cytokines in mouse models of intestinal cancer. The mesenteric lymph nodes of H. hepaticus-infected, IL-10-deficient 129 strain mice show large numbers of IL-17þ cells residing mainly in paracortical and medullary areas. IL-17þ cells are histomorphologically consistent with macrophages and lymphocytes (A). Adoptive transfer of IL-10 -/regulatory T cells into H. hepaticus-infected, Rag2-deficient mice rapidly promotes CRC with peritoneal invasion and simultaneously increases significantly the numbers of IL-17þ cells in lymph nodes (B). Neutrophils are found to be major sources of both TGF-b1(C) and IL-6 (D) within the colonic mucosa. Under these pro-inflammatory conditions, Foxp3þ cells are numerous in the mesenteric lymph nodes (E). Intratumoral Foxp3þ cells within adenomatous polyps of Apc Min/þ mice were numerous within regressing polyps after anti-TNFa-treated Apc Min/þ mice (F). 3,3-diaminobenzidine, hematoxylin counterstain. Bars: A-D, 50 mm; E-G, 25 mm. multiplicity and features of neoplastic invasion (Table 1) , coincident with elevated expression levels of TNF-a, IL-6 and IL-17, but failed to induce IBD in Apc Min/þ mice . Interestingly, female Apc Min/þ recipients of pro-inflammatory T EFF were at increased risk for mammary carcinoma . Taken together with the finding that pathogenic gut bacterial infections may trigger carcinogenesis in distant sites such as mammary tissue in mice (Rao, Poutahidis, Ge, Nambiar, Boussahmain, et al. 2006) , these data support the concept that health and disease throughout the body is subject to immune events arising in mucosal surfaces of the bowel. Rao, Poutahidis, Ge, Nambiar, Boussahmain et al. (2006) used the T REG cell titration assay to test whether prior GI bacterial infections protect Apc Min/þ mice from intestinal polyps. T REG cells from H. hepaticus-infected donors consistently provided complete protection from cancer and more effectively suppressed pro-inflammatory cytokines TNF-a, IL-6, and IL-17 levels in tumor-prone tissues when compared with T REG from uninfected ''hygienic'' donor mice. These studies showed that protection from cancer is attributable to functions of T REG cells and is more dependent upon the prior conditions of the T REG rather than that of the recipient animals. In some cases, gut bacteria-imbued T REG protection from cancer was more significant in distant sites such as mammae in mice Rao, Poutahidis, Ge, Nambiar, Boussahmain, et al. 2006) . Amazingly, prior gut bacterial exposures also significantly enhanced ability of T REG to increase life expectancy in Apc Min/þ mice (Erdman, Rao, Olipitz et al., 2009 ). These findings raised the possibility that constructive functions of T REG may be applied therapeutically in a wide variety of chronic inflammatory disorders to improve overall health.
FOXP3þ CELL LOCALIZATION IN CANCER
Foxp3 is a widely accepted marker of T REG cells (Bettelli et al. 2006) . We have found that under chronic inflammatory conditions, Foxp3þ T REG are increased in circulation and accumulate in large numbers in lymph nodes and surrounding tumors ( Figure  5E ). However, we have found that tumor-infiltrating Foxp3þ cells are seen primarily during regression of the tumors, as after treatment with anti-TNF-a antibody (Rao, Poutahidis, Ge, Nambiar, Boussahmain, et al. 2006; ) ( Figure 5F ). In human CRC patients, intratumoral Foxp3þ cells were recently correlated with a favorable clinical outcome (Salama et al. 2009 ). One intriguing possibility is that T REG not only have diminished efficacy during inflammation but also differentiate directly into IL-17-producing cells (Koenen et al. 2008; Radhakrishnan et al. 2008) in the inflammatory milieu surrounding the growing tumor. In our hands, anti-inflammatory treatments such as anti-TNF-a or exogenous IL-10 led to significantly decreased counts of Foxp3þ cells in the periphery and increased Foxp3þ cells within the tumor parenchyma, commensurate with tumor regression.
SUMMARY AND CONCLUSIONS
It has been well established in humans and in mice that chronic bacteria-triggered inflammation increases the risk of colonic cancer (Bromberg and Wang 2009; Erdman, Rao, Poutahidis et al. 2009; Gounaris et al. 2007; Poutahidis et al. 2007; Rao, Poutahidis, Ge, Nambiar, Boussahmain, et al. 2006; Poutahidis et al. 2009; ). Paradoxically, the risk of humans developing CRC is lower in countries that have less stringent hygiene practices with early life exposures to numerous pathogenic bacteria (ACS 2004; Fox et al. 2000) . Accumulated data from our lab and others help explain this enigma. Microbial exposures early in life serve to reinforce the immune system through an IL-10-and T REG -mediated feedback loop, which, in turn, conveys protection from inflammatory challenges later in life and reduces the risk of inflammation-associated cancers. Sporadic intestinal cancers arising from adenomatous polyps fit this inflammatory bowel paradigm, even in the absence of overt IBD. T REG cells appear to restore intestinal homeostasis through immune tolerance to intestinal bacteria, as proposed by Kullberg et al. (2002) , Powrie and Maloy (2003) , and Mazmanian and coworkers (Chow and Mazmanian 2009; Mazmanian et al. 2008) . Dysregulation of this protective process leads to chronic inflammation with elevated levels of IL-6, impaired T REG , and a Th-17 host response, as described by Bettelli and coworkers (Bettelli et al. 2006; Bettelli, Oukka, and Kuchroo 2007) . Extrapolating these results to humans, individuals with a naïve immune system and weakened IL-10-and T REG -mediated inhibitory loop would be FIGURE 6.-Proposed carcinogenic and protective roles for gut bacteria in cancer. Chronic pathogenic intestinal bacterial infections trigger a well-established sequence of immune events leading to cancer. However, microbial exposures earlier in life also serve to reinforce IL-10and T REG -mediated protection from inflammatory disorders, which, in turn, conveys protection from inflammation-associated cancers later in life. Stringent hygiene practices deprive the immune system of routine stimulation by bacterial products and IL-10 needed for efficient immune function. Thus, individuals with a naïve immune system and weakened IL-10-and T REG -mediated inhibitory loop have increased susceptibility to uncontrolled inflammation and are at increased risk for inflammation-associated cancers. Insufficient early life microbial exposures in societies with stringent hygiene practices may serve to undermine protective immunity and lower the threshold for future carcinogenic events. Modified from Rao et al. (2007) . 84 ERDMAN AND POUTAHIDIS TOXICOLOGIC PATHOLOGY more susceptible to uncontrollable elevations in inflammation and IL-6 and IL-17, and they would show more frequent inflammation-associated cancers in response to proinflammatory challenges later in life. Taken together, these data help explain interrelated roles of gut bacteria, inflammation, and T REG cells. Although it is widely believed that T REG interfere with constructive antitumor host responses (Colombo et al. 2007; Curiel et al. 2004) , our data show that T REG function in cancer similarly to other inflammatory disorders involving TNF-a, IL-6, and a Th-17 host response. Anti-inflammatory properties of T REG within the bowel clearly serve to routinely inhibit destructive process and promote health throughout the body. Under pro-inflammatory host conditions, however, T REG fail to inhibit inflammation and instead may fuel carcinogenic events by contributing to host pro-inflammatory responses. This outcome is displayed under conditions of insufficient IL-10 or with stringent hygiene practices in youth. Insufficient early life microbial exposures in modern society may serve to undermine protective immunity and lower the threshold for future carcinogenic events. first showed that neutralization of pro-inflammatory cytokine TNF-a is sufficient to induce intestinal tumor remission in Apc Min/þ mice. Therapeutic interventions such as infliximab and etanercept are widely used in human patients with inflammatory disorders (Ehrenstein et al. 2004; Pereg and Lishner 2005) and could rapidly be translated into CRC therapy in humans. These emerging data highlight the importance of better understanding T REG biology in cancer to exploit host immunity as a powerful tool in cancer therapy. Targeting the underlying inflammatory causes and reinforcing beneficial systemic roles for T REG may yield enormous benefits to eradicate cancer. Harnessing the power of the immune system may provide more effective and less toxic alternatives to traditional chemotherapy for treatment of cancer.
